课题基金 / 基金详情

Disruption of cytoplasmic membrane-associated functions in Staphylococcus aureus by epicatechin gallate

Disruption of cytoplasmic membrane-associated functions in Staphylococcus aureus by epicatechin gallate
表儿茶素没食子酸酯破坏金黄色葡萄球菌细胞质膜相关功能
批准号:
BB/I005579/1
负责人:
Peter Taylor
金额:
$42.14万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --

项目摘要

项目成果

Peter Taylor的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Staphylococcus aureus is commonly encountered as a coloniser of skin and mucosa but gives rise to a range of infections when there is an opportunity for the bacteria to enter the body. It also makes a range of toxins that are responsible for food poisoning: if food workers carry the bacterium, it can enter the food chain and will survive even in salty foods due to its ability to tolerate salt. Staphylococci show a remarkable capacity to resist the action of commonly used antibiotics through the acquisition of resistance mechanisms. In particular, they can acquire the mecA gene, whose product penicillin binding protein (PBP) 2a allows it to survive in the presence of high concentrations of penicillins such as methicillin and oxacillin. Such methicillin-resistant S. aureus (MRSA) are a threat to patients entering hospitals, particularly for major surgery, and are increasingly acquired in the community. At one time these infections were confined to humans but in recent years have been encountered in companion animals, especially dogs and cats; in all likelihood the bacteria were initially acquired from humans. Animal and human MRSA infections are difficult to treat and new approaches to therapy and control are urgently needed, in particular those that reduce the rate of emergence of drug resistance. We have established that one of the major components of green tea, a relatively labile substance termed epicatechin gallate, or ECg, alters the properties of S. aureus in a way that should be beneficial to animals and humans. Although ECg has no effect on the growth rate of MRSA, it reduces their resistance to penicillins by a much as five hundredfold, raising the possibility that it can be used alongside conventional antibiotics to treat infections. As ECg modifies rather than kills the target bacteria, it will not apply the same degree of extreme selective pressure as currently used 'bactericidal' drugs and may slow the emergence of resistance to therapeutic combinations. Additionally, we have discovered that ECg prevents the secretion of toxins and enzymes that enable the organism to cause tissue damage and infection and that are responsible for the symptoms of food poisoning. ECg also prevents the formation of biofilms: these complex assemblages of bacteria form at interfaces and are a necessary prerequisite for colonisation of host surfaces and devices such as catheters and prostheses prior to tissue invasion. Unfortunately, the naturally occurring chemical is not ideal for therapeutic purposes due to its labile nature and moderate activity and we are making derivatives of ECg with a more attractive profile. These attempts are hampered by an incomplete understanding of how ECg exerts its anti-staphylococcal activities. We are beginning to learn that it possesses such wide-ranging properties because i inserts into the bacterial membrane, a structure that is home to many essential enzymatic cellular functions. We know that the compound changes the properties of the membrane in a way that will affect the proteins embedded in it. For example, penicillin resistance is due to cooperation between two PBPs, 2 and 2a, enabling the bacteria to continue to make cell wall in the presence of the drug. We will determine if ECg disrupts this complex at the site of cell division or if it simply detaches the complex in a way that allows continued synthesis at 'wrong' sites. It is becoming apparent that the fine detail of the lipid environment in the region of cell division is critical to the determination of efficient bacterial replication; we will examine the way in which ECg alters this parameter. Finally, the capacity of ECg to increase salt sensitivity of staphylococci means that it could become an effective agent for preserving food and preventing the elaboration of toxins associated with food poisoning. The bacteria pump out sodium ions using membrane-located proteins and we will examine the capacity of ECg to compromise this mechanism.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1128/jb.00698-17
发表时间: 2018-04-01
期刊: Journal of bacteriology
影响因子: 3.2
作者: [McCarthy AJ, Stabler RA, Taylor PW]
通讯作者: Taylor PW
Effect of Epicatechin Gallate on the Cell Envelope of Methicillin-Resistant Staphylococcus aureus
表儿茶素没食子酸酯对耐甲氧西林金黄色葡萄球菌细胞包膜的影响
DOI: --
发表时间:
期刊:
影响因子: --
作者: [Peter Taylor (Author)]
通讯作者: Peter Taylor (Author)
The Impact of Epicatechin Gallate on the Structural Integrity of the PBP2-PBP2a Division Complex in Methicillin Resistant Staphylococcus aureus
表儿茶素没食子酸酯对耐甲氧西林金黄色葡萄球菌 PBP2-PBP2a 分裂复合物结构完整性的影响
DOI: --
发表时间:
期刊:
影响因子: --
作者: [Peter Taylor (Author)]
通讯作者: Peter Taylor (Author)
Non-invasive three-dimensional imaging of Escherichia coli K1 infection using diffuse light imaging tomography combined with micro-computed tomography.
使用漫射光成像断层扫描结合微型计算机断层扫描对大肠杆菌 K1 感染进行无创三维成像。
DOI: 10.1016/j.ymeth.2017.05.005
发表时间: 2017
期刊: Methods (San Diego, Calif.)
影响因子: --
作者: [Witcomb LA]
通讯作者: Witcomb LA
[SurgeryNet] Epilepsy surgery induced brain network changes: relation to patient outcomes
  • 批准号:
    MR/T04294X/1
  • 项目类别:
    Fellowship
  • 资助金额:
    $105.33万
  • 财政年份:
    2021
  • 负责人:
    Peter Taylor
  • 依托单位:
Biocatalytic Approaches to the Synthetic Manipulation of Silicones
  • 批准号:
    EP/S013660/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $4.34万
  • 财政年份:
    2019
  • 负责人:
    Peter Taylor
  • 依托单位:
Molecular mechanisms of enterobacterial resistance to complement
  • 批准号:
    MR/R009937/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $98.46万
  • 财政年份:
    2018
  • 负责人:
    Peter Taylor
  • 依托单位:
Treatment of multi-drug-resistant Gram-negative bacterial infections using capsule depolymerases
  • 批准号:
    MR/N012542/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $48.8万
  • 财政年份:
    2016
  • 负责人:
    Peter Taylor
  • 依托单位:
国内基金
海外基金
胞浆或核定位蛋白质的O-GalNAc糖基化研究
  • 批准号:
    31170771
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2011
  • 负责人:
    张延
  • 依托单位:
棉花细胞质雄性不育及育性恢复机理的分子解析
  • 批准号:
    31171591
  • 项目类别:
    面上项目
  • 资助金额:
    66.0万元
  • 批准年份:
    2011
  • 负责人:
    华金平
  • 依托单位:
辣椒胞质雄性不育恢复性主效基因精密图谱分析